Australian Institute of Health and Welfare 2021. Cancer data in Australia. Cat. no. CAN 122. Canberra: AIHW. Viewed 19 October 2021, https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia
Australian Institute of Health and Welfare. (2021). Cancer data in Australia. Retrieved from https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia
Cancer data in Australia. Australian Institute of Health and Welfare, 08 June 2021, https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia
Australian Institute of Health and Welfare. Cancer data in Australia [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2021 Oct. 19]. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia
Australian Institute of Health and Welfare (AIHW) 2021, Cancer data in Australia, viewed 19 October 2021, https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia
Get citations as an Endnote file:
PDF | 3.3Mb
For around 70 cancers, this data visualisation provides a range of cancer survival statistics. Help with terms, and information about the data, is available by placing the mouse pointer over the boxes found near the top of the dashboard.
Cancer survival: snapshot. Observed and relative survival rates for selected cancers, by sex and age, from 1987-1991 to 2012-2016.
This visualisation contains survival information for around 60 cancers divided across Figures 1 to 4.
Figure 1 is a line graph that contains information on 1 to 5-year observed or relative survival rates for the selected cancer from 1987–1991 to 2012–2016.
Figure 2 is a column graph that contains information on 1 to 5-year observed or relative survival rates by sex for the selected cancer for the most recent period 2012–2016.
Figure 3 is a line graph that contains information on 1 to 5-year observed or relative survival rates for the selected cancer in order of increasing age group (0–4, 5–9, etc. up to 90+) for the most recent period 2012–2016.
Figure 4 is a line graph that contains 5-year conditional observed or relative survival, given the person has already survived 1 to 15 years after diagnosis, for the selected cancer in the most recent period 2012–2016.
Cancer survival data is available as supplementary tables.
ABS (Australian Bureau of Statistics) 2018. Population projections, Australia, 2017 (base) – 2066. ABS cat. no. 3222.0. Canberra: ABS.
AIHW (Australian Institute of Health and Welfare) 2019. BreastScreen Australia monitoring report 2018. Cancer series no.127. Cat no. CAN128. Canberra: AIHW
Al-Marhoon M, Osman A, Kamal M and Shokier A 2011. Incidental vs symptomatic renal tumours: Survival outcomes. Arab Journal of Urology 9(1): 17–21.
Brenner H and Gefeller O 1996. An alternative approach to monitoring cancer patient survival. Cancer78:2004–10.
Dickman PW 2004. Estimating and modelling relative survival using SAS. Stockholm: Karolinska Institutet. Viewed 26 May 2020.
Ederer F & Heise H 1959. Instructions to IBM 650 programmers in processing survival computations. Methodological note.
Greenwood M 1926. The errors of sampling of the survivorship table. Reports on public health and medical subjects. Vol 33. London: Her Majesty’s Stationery Office.
Jensen O, Parkin D, MacLennan R, Muir C & Skeet R (eds) 1991. Cancer registration: principles and methods. IARC scientific publications no. 95. Lyon: IARC.
Luke C, Tracey E, Stapleton A and Roder D 2010. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for cancer research and cancer control. Internal Medicine Journal 40:357–62.
Qaseem A, Usman N, Jayaraj J S, et al. (September 02, 2019) Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site. Cureus 11(9): e5552. doi:10.7759/cureus.5552
Skuladottir H & Olsen JH 2003. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. Journal of Clinical Oncology 21(16):3035–40.
Smith D Supramaniam R, Marshall V and Armstrong B 2008. Prostate cancer and prostate specific antigen testing in New South Wales. Medical Journal of Australia 189(6): 315–18.
Vaccarella S, Franceschi S, Bray F, Wild C, Plummer M and Dal Maso L 2016. The increase in thyroid cancer may be due to an increase in medical surveillance and the introduction of new diagnostic techniques, such as neck ultrasonography. The New England Journal of Medicine 375: 614–17.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.